WHO develops and issues considerable information regarding vaccines for specific diseases. This includes within its Technical Report Series, within the meeting reports of the WHO Expert Committee on Biological Standardization, and as WHO Vaccine Postion papers. It is relevant to many different vaccines stakeholders, including regulators who oversee licensing and production of vaccines, vaccines manufacturers, procurers who procure vaccines for national immunization programmes, and health care providers who administer vaccines to at-risk populations.

This information on vaccines for specific diseases can be accessed via the links below:

• BCG (tuberculosis)
• Cholera
• Combined DT-based vaccines (e.g. for diptheria and tetanus)
• Coronavirus (COVID-19)
• Dengue
• Diphtheria
• DNA vaccines
• Ebola virus disease
• Enterovirus 71
• Haemorrhagic fever with renal syndrome
• Haemophilus influenzae type b (Hib)
• Hepatitis A, Hepatitis B, Hepatitis E
• Human papillomavirus
• Influenza
• Japanese encephalitis (JE)
• Malaria
• Measles
• Meningococcal meningitis
• Messenger RNA vaccines
• Mumps
• Pertussis
• Plant-derived vaccines
• Pneumococcus
• Poliomyelitis
• Rabies
• Respiratory syncytial virus (RSV)
• Rift Valley fever
• Rotavirus
• Rubella (German measles)
• Smallpox
• Synthetic peptide vaccines
• Tetanus
• Tick-borne encephalitis
• Typhoid fever
• Varicella (chickenpox)
• Viral vector vaccines
• Yellow fever